NCT03436823

Brief Summary

Repeated Transcranial Magnetic Stimulation - R.TMS - is currently part of the treatment for depressive illness. This non-invasive technique is designed to stimulate certain areas of the cerebral cortex involved in this pathology. FDA approved this treatment in routine for depressive illness. R.TMS still remains in assessment. Due to the heterogeneity of methods and the weakness of the cohorts therapeutic superiority can not concluded . Stimulation parameters remain numerous even if a consensus is beginning to emerge. The therapeutic target is the left dorso - lateral prefrontal cortex. The lack of efficacy is probably due of the inaccuracy. The empirically location of the target does not take into account the inter-individual anatomical differences. The neuronavigation is becoming widespread in routine clinical practice. The referent nurse stays with the patient all along the rTMS sessions. His role is to set up treatment, to ensure the safety and the well-being of the patient. An rTMS session is an average of 30 minutes and is a very special moment to create a specific therapeutic relationship. No study was conducted to evaluate the therapeutic relationship. The assumption is made that rTMS with a semi - structured interview provides a qualitative and quantitative clinical response greater than a semi - structured rTMS without this nursing care. The investigators therefore propose to patients not receiving a semi-structured interview to listen to music with eyes closed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
28 days until next milestone

Study Start

First participant enrolled

March 19, 2018

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2023

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

4.8 years

First QC Date

February 12, 2018

Last Update Submit

January 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • score of the Montgomery-Asberg Depression Rating Scale

    The ratings should be based on a clinical interview moving from broadly phrased questions about symptoms to more detailed ones which allow a precise rating of severity. The rater must decide whether the rating lies on the defined scale steps (0, 2, 4, 6) or between them (1, 3, 5). It is important to remember that it is only rare occasions that a depressed patient is encountered who cannot be rated on the items in the scale. If definite answers cannot be elicited from the patients, all relevant clues as well as information from other sources should be used as a basis for the rating in line with customary clinical practice.

    day 44

Study Arms (2)

R.TMS + nurse semi-structured interview

EXPERIMENTAL

Repeated Transcranial Magnetic Stimulation sessions associated with nurse semi-structured interview

Other: nurse semi-structured interview

R.TMS + Music & Relaxation

SHAM COMPARATOR

Repeated Transcranial Magnetic Stimulation sessions associated with music listening \& relaxation with eyes closed

Other: Music & Relaxation with eyes closed

Interventions

The first session of rTMS is D1. From the first meeting to D14 semi -structured interviews are set up

R.TMS + nurse semi-structured interview

The first session of rTMS is D1. From the first meeting to D14 music \& relaxation with eyes closed sessions are set up

R.TMS + Music & Relaxation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients volunteers aged 18 to 70,
  • With the diagnosis of major depression, recurrent under the criteria of DSM.V,
  • With an unmodified antidepressant treatment for 3 weeks,
  • With a MADRS score greater than or equal to 21,
  • With or without neuronavigated rTMS sessions,
  • Informed and who have signed a consent.

You may not qualify if:

  • Patients with psychotic symptoms,
  • With alcohol dependence or other substances abuse,
  • With the strength criteria defined by the V stage for Classification of Thase \& Rush,
  • Hospitalized without consent / or under legal protection for major.
  • With a high risk of suicide - item 10 of the MADRS\> 3 in the absence of hospitalization,
  • With contraindications to the practice of MRI or rTMS due to previous seizures, neurological disorders and / or neurosurgical, metal prosthetic presence or foreign bodies pacemaker type intraocular ferromagnetic material,
  • Aged over 70 years due to cortical alteration,
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHGR

Rennes, France

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Dominique Drapier, MD

    Centre Hospitalier Guillaume Régnier,

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2018

First Posted

February 19, 2018

Study Start

March 19, 2018

Primary Completion

January 6, 2023

Study Completion

January 6, 2023

Last Updated

January 20, 2023

Record last verified: 2023-01

Locations